Cargando…

Robust growth of avirulent phase II Coxiella burnetii in bone marrow-derived murine macrophages

Published data show that murine bone marrow-derived macrophages (BMDM) restrict growth of avirulent phase II, but not virulent phase I, Coxiella burnetii. Growth restriction of phase II bacteria is thought to result from potentiated recognition of pathogen-associated molecular patterns, which leads...

Descripción completa

Detalles Bibliográficos
Autores principales: Cockrell, Diane C., Long, Carrie M., Robertson, Shelly J., Shannon, Jeffrey G., Miller, Heather E., Myers, Lara, Larson, Charles L., Starr, Tregei, Beare, Paul A., Heinzen, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344453/
https://www.ncbi.nlm.nih.gov/pubmed/28278296
http://dx.doi.org/10.1371/journal.pone.0173528
_version_ 1782513545778298880
author Cockrell, Diane C.
Long, Carrie M.
Robertson, Shelly J.
Shannon, Jeffrey G.
Miller, Heather E.
Myers, Lara
Larson, Charles L.
Starr, Tregei
Beare, Paul A.
Heinzen, Robert A.
author_facet Cockrell, Diane C.
Long, Carrie M.
Robertson, Shelly J.
Shannon, Jeffrey G.
Miller, Heather E.
Myers, Lara
Larson, Charles L.
Starr, Tregei
Beare, Paul A.
Heinzen, Robert A.
author_sort Cockrell, Diane C.
collection PubMed
description Published data show that murine bone marrow-derived macrophages (BMDM) restrict growth of avirulent phase II, but not virulent phase I, Coxiella burnetii. Growth restriction of phase II bacteria is thought to result from potentiated recognition of pathogen-associated molecular patterns, which leads to production of inhibitory effector molecules. Past studies have used conditioned medium from L-929 murine fibroblasts as a source of macrophage-colony stimulating factor (M-CSF) to promote differentiation of bone marrow-derived myeloid precursors into macrophages. However, uncharacterized components of conditioned medium, such as variable amounts of type I interferons, can affect macrophage activation status and their permissiveness for infection. In the current study, we show that the C. burnetii Nine Mile phase II (NMII) strain grows robustly in primary macrophages from C57BL/6J mice when bone marrow cells are differentiated with recombinant murine M-CSF (rmM-CSF). Bacteria were readily internalized by BMDM, and replicated within degradative, LAMP1-positive vacuoles to achieve roughly 3 logs of growth over 6 days. Uninfected BMDM did not appreciably express CD38 or Egr2, markers of classically (M1) and alternatively (M2) activated macrophages, respectively, nor did infection change the lack of polarization. In accordance with an M0 phenotype, infected BMDM produced moderate amounts of TNF and nitric oxide. Similar NMII growth results were obtained using C57BL/6J myeloid progenitors immortalized with an estrogen-regulated Hoxb8 (ER-Hoxb8) oncogene. To demonstrate the utility of the ER-Hoxb8 system, myeloid progenitors from natural resistance-associated macrophage protein 1 (Nramp1) C57BL/6J knock-in mice were transduced with ER-Hoxb8, and macrophages were derived from immortalized progenitors using rmM-CSF and infected with NMII. No difference in growth was observed when compared to macrophages from wild type mice, indicating depletion of metal ions by the Nramp1 transporter does not negatively impact NMII growth. Results with NMII were recapitulated in primary macrophages where C57BL/6J Nramp1+ BMDM efficiently killed Salmonella enterica serovar Typhimurium. M-CSF differentiated murine macrophages from bone marrow and conditional ER-Hoxb8 myeloid progenitors will be useful ex vivo models for studying Coxiella-macrophage interactions.
format Online
Article
Text
id pubmed-5344453
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-53444532017-03-29 Robust growth of avirulent phase II Coxiella burnetii in bone marrow-derived murine macrophages Cockrell, Diane C. Long, Carrie M. Robertson, Shelly J. Shannon, Jeffrey G. Miller, Heather E. Myers, Lara Larson, Charles L. Starr, Tregei Beare, Paul A. Heinzen, Robert A. PLoS One Research Article Published data show that murine bone marrow-derived macrophages (BMDM) restrict growth of avirulent phase II, but not virulent phase I, Coxiella burnetii. Growth restriction of phase II bacteria is thought to result from potentiated recognition of pathogen-associated molecular patterns, which leads to production of inhibitory effector molecules. Past studies have used conditioned medium from L-929 murine fibroblasts as a source of macrophage-colony stimulating factor (M-CSF) to promote differentiation of bone marrow-derived myeloid precursors into macrophages. However, uncharacterized components of conditioned medium, such as variable amounts of type I interferons, can affect macrophage activation status and their permissiveness for infection. In the current study, we show that the C. burnetii Nine Mile phase II (NMII) strain grows robustly in primary macrophages from C57BL/6J mice when bone marrow cells are differentiated with recombinant murine M-CSF (rmM-CSF). Bacteria were readily internalized by BMDM, and replicated within degradative, LAMP1-positive vacuoles to achieve roughly 3 logs of growth over 6 days. Uninfected BMDM did not appreciably express CD38 or Egr2, markers of classically (M1) and alternatively (M2) activated macrophages, respectively, nor did infection change the lack of polarization. In accordance with an M0 phenotype, infected BMDM produced moderate amounts of TNF and nitric oxide. Similar NMII growth results were obtained using C57BL/6J myeloid progenitors immortalized with an estrogen-regulated Hoxb8 (ER-Hoxb8) oncogene. To demonstrate the utility of the ER-Hoxb8 system, myeloid progenitors from natural resistance-associated macrophage protein 1 (Nramp1) C57BL/6J knock-in mice were transduced with ER-Hoxb8, and macrophages were derived from immortalized progenitors using rmM-CSF and infected with NMII. No difference in growth was observed when compared to macrophages from wild type mice, indicating depletion of metal ions by the Nramp1 transporter does not negatively impact NMII growth. Results with NMII were recapitulated in primary macrophages where C57BL/6J Nramp1+ BMDM efficiently killed Salmonella enterica serovar Typhimurium. M-CSF differentiated murine macrophages from bone marrow and conditional ER-Hoxb8 myeloid progenitors will be useful ex vivo models for studying Coxiella-macrophage interactions. Public Library of Science 2017-03-09 /pmc/articles/PMC5344453/ /pubmed/28278296 http://dx.doi.org/10.1371/journal.pone.0173528 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Cockrell, Diane C.
Long, Carrie M.
Robertson, Shelly J.
Shannon, Jeffrey G.
Miller, Heather E.
Myers, Lara
Larson, Charles L.
Starr, Tregei
Beare, Paul A.
Heinzen, Robert A.
Robust growth of avirulent phase II Coxiella burnetii in bone marrow-derived murine macrophages
title Robust growth of avirulent phase II Coxiella burnetii in bone marrow-derived murine macrophages
title_full Robust growth of avirulent phase II Coxiella burnetii in bone marrow-derived murine macrophages
title_fullStr Robust growth of avirulent phase II Coxiella burnetii in bone marrow-derived murine macrophages
title_full_unstemmed Robust growth of avirulent phase II Coxiella burnetii in bone marrow-derived murine macrophages
title_short Robust growth of avirulent phase II Coxiella burnetii in bone marrow-derived murine macrophages
title_sort robust growth of avirulent phase ii coxiella burnetii in bone marrow-derived murine macrophages
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344453/
https://www.ncbi.nlm.nih.gov/pubmed/28278296
http://dx.doi.org/10.1371/journal.pone.0173528
work_keys_str_mv AT cockrelldianec robustgrowthofavirulentphaseiicoxiellaburnetiiinbonemarrowderivedmurinemacrophages
AT longcarriem robustgrowthofavirulentphaseiicoxiellaburnetiiinbonemarrowderivedmurinemacrophages
AT robertsonshellyj robustgrowthofavirulentphaseiicoxiellaburnetiiinbonemarrowderivedmurinemacrophages
AT shannonjeffreyg robustgrowthofavirulentphaseiicoxiellaburnetiiinbonemarrowderivedmurinemacrophages
AT millerheathere robustgrowthofavirulentphaseiicoxiellaburnetiiinbonemarrowderivedmurinemacrophages
AT myerslara robustgrowthofavirulentphaseiicoxiellaburnetiiinbonemarrowderivedmurinemacrophages
AT larsoncharlesl robustgrowthofavirulentphaseiicoxiellaburnetiiinbonemarrowderivedmurinemacrophages
AT starrtregei robustgrowthofavirulentphaseiicoxiellaburnetiiinbonemarrowderivedmurinemacrophages
AT bearepaula robustgrowthofavirulentphaseiicoxiellaburnetiiinbonemarrowderivedmurinemacrophages
AT heinzenroberta robustgrowthofavirulentphaseiicoxiellaburnetiiinbonemarrowderivedmurinemacrophages